Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes

Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes

PurposeThe aims of this study were to evaluate and compare fibroblast activation protein (FAP) expression and localization in surgically resected cholangiocarcinoma (CCA), primary and metastatic hepatocellular carcinoma (HCC), hepatocellular adenoma (HCA), and focal nodular hyperplasia (FNH), and to...

Full description

Bibliographic Details
Main Authors: Laura C. Jorgenson, Michael S. Torbenson, Thorvardur R. Halfdanarson, Lionel A. Kankeu Fonkoua, Nguyen H. Tran, Lewis R. Roberts, Rory L. Smoot, Ajit H. Goenka, Scott M. Thompson
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Nuclear Medicine
Subjects:
cholangiocarcinoma (CCA)
fibroblast activation protein (FAP)
liver neoplasms
precision medicine
theranostics
Online Access:https://www.frontiersin.org/articles/10.3389/fnume.2024.1480471/full

Internet

https://www.frontiersin.org/articles/10.3389/fnume.2024.1480471/full

Similar Items